These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9123373)

  • 41. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 45. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of IgA anti-HLA class I antibodies in kidney transplant survival.
    Koka P; Chia D; Terasaki PI; Chan H; Chia J; Ozawa M; Lim E
    Transplantation; 1993 Jul; 56(1):207-11. PubMed ID: 8333044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 48. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 49. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 50. The impact of race and HLA matching on long-term survival following cardiac transplantation.
    Park MH; Tolman DE; Kimball PM
    Transplant Proc; 1997; 29(1-2):1460-3. PubMed ID: 9123381
    [No Abstract]   [Full Text] [Related]  

  • 51. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants.
    Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival.
    Kerman RH; Sullivan EK; Tejani A
    Transplant Proc; 1995 Feb; 27(1):656-7. PubMed ID: 7879133
    [No Abstract]   [Full Text] [Related]  

  • 55. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 56. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
    Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
    Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
    Varghese Z; Abudher MN; Fernando ON; Moorhead JF
    Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
    [No Abstract]   [Full Text] [Related]  

  • 58. Class I peptides involved in the indirect pathway of allorecognition.
    Takemoto SK; Cecka JM; Gjertson DW; Terasaki PI
    Transplant Proc; 1999; 31(1-2):781. PubMed ID: 10083332
    [No Abstract]   [Full Text] [Related]  

  • 59. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
    Inoue S; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.